Natural killer cell tag sponsored by:
Natural killer cell
-
Phase 2 Findings Show Wugen’s Investigational Allogeneic CAR-T, WU-CART-007, Was Highly Effective and Surpassed Standard of Care in Treating Hard-to-Treat T-ALL / LBL; Data Presented Today at European Hematology Association (EHA) 2024 Hybrid Congress |
wugen.com | | Article Details | Related Articles